GE May Sell Spacelabs to Meet Concerns of European Regulators
|
By HospiMedica staff writers Posted on 31 Jul 2003 |
In order to get regulatory approval from the European Commission (EC) for its proposed US$2.3 billion acquisition of Instrumentarium (Helsinki, Finland), GE Medical Systems (Waukesha, WI, USA) is rumored to be considering the sale of Spacelabs (Bothell, WA, USA), a division of Instrumentarium.
Spacelabs was acquired by Instrumentarium in July 2002. The company makes and markets products for emergency and critical care, including monitoring and anesthesia equipment, as well as perioperative, neonatal, and obstetrical products. In 2002, the company had total revenues of $242 million.
GE is a major global supplier of medical imaging systems. The company's 2001 sales were $8 billion. By 2005, GE is aiming for sales to grow to about $15 million.
The European Commission has voiced its concerns that once combined, GE and Instrumentarium would have a large share of patient monitoring devices and imaging equipment used in hospitals and might be able to squeeze out smaller suppliers. The deadline for any proposals from GE is in mid-August. US regulators have not yet approved the deal, either.
Related Links:
Instrumentarium
GE Medical Systems
Spacelabs
Spacelabs was acquired by Instrumentarium in July 2002. The company makes and markets products for emergency and critical care, including monitoring and anesthesia equipment, as well as perioperative, neonatal, and obstetrical products. In 2002, the company had total revenues of $242 million.
GE is a major global supplier of medical imaging systems. The company's 2001 sales were $8 billion. By 2005, GE is aiming for sales to grow to about $15 million.
The European Commission has voiced its concerns that once combined, GE and Instrumentarium would have a large share of patient monitoring devices and imaging equipment used in hospitals and might be able to squeeze out smaller suppliers. The deadline for any proposals from GE is in mid-August. US regulators have not yet approved the deal, either.
Related Links:
Instrumentarium
GE Medical Systems
Spacelabs
Latest Business News
- Terumo Neuro Acquisition Advances Liquid Embolic Technology for Chronic Subdural Hematoma
- World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition
- Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery
- Robotic Single-Port System Gains CE Mark for Transvaginal Gynecologic Procedures
- Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award
- Partnership Advances AI Tool for Predicting Malignant Cerebral Edema
- First U.S. Commercial Cases Demonstrate New Approach to Transseptal Access
- Philips and Imricor Collaboration Advances MRI-Guided Cardiac Procedures
- FDA Approval Clears Path for BCI Integration with Personal Computing Devices
- Abbott LAA Occluder Gains CE Mark for AFib Stroke Risk Reduction
- Smart Hospital Market Set for Strong Growth as Digital Healthcare Adoption Accelerates
- FDA Seeks Feedback on Regulating Generative AI Medical Devices
- Teledyne to Acquire Varex Imaging in $1.1 Billion Deal
- MIMEDX to Add Sanara MedTech’s Regenerative Technologies Through $350 Million Deal
- AI Software Combines Nodule Detection and Diagnosis for Lung Cancer Screening
- AI Care Platform Adds Quantitative MRI Analysis for Multiple Sclerosis
Channels
Artificial Intelligence
view channel
AI Tool Predicts Long-Term Cardiovascular Risk from Sleep Study ECG
Sleep disorders such as insomnia and obstructive sleep apnea are established cardiovascular risk factors and are commonly evaluated with overnight polysomnography. These studies routinely record electrocardiogram... Read more
Predictive Model Supports Growth Hormone Treatment Planning in Idiopathic Short Stature
Idiopathic short stature (ISS) describes children whose height is substantially below the expected range for age and sex without an identifiable medical cause. Recombinant growth hormone therapy can support... Read moreCritical Care
view channel
Wristwatch Sensor Tracks Sodium and Potassium in Sweat in Real Time
Sweat can provide real-time biochemical information about the body’s physiological state, with sodium and potassium measurements offering potential value for monitoring people working or exercising in... Read more
Wearable Patch Prototype Advances Toward Integrated Automated Insulin Delivery
Diabetes management requires individualized care, reliable glucose and ketone monitoring, and timely intervention. For automated insulin delivery, a key challenge is maintaining accurate glucose measurements... Read more
AI Tool Combining ECG and Blood Tests Reduces Unnecessary Heart Transplant Biopsies
Cardiac transplant rejection occurs when a recipient’s immune system attacks a donated heart. Diagnosis currently relies on biopsy, an invasive procedure in which heart muscle tissue is removed and examined... Read moreSurgical Techniques
view channel
Tiny Robots Could Speed Targeted Drug Delivery to Heart Infections
Endocarditis is an infection of heart tissue that can become life-threatening when treatment fails to reach the infected site. About 50,000 people in the United States develop the condition each year.... Read more
Contact Radiotherapy Offers New Organ-Preserving Approach for Rectal Cancer
Tampere University Hospital, known as Tays, is the first hospital in Finland to introduce contact radiotherapy for rectal cancer using high-dose-rate brachytherapy, or HDR brachytherapy.... Read morePatient Care
view channel
AI Platform Personalizes Support Between Visits for Cancer Survivors
Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more
At-Home Neuromodulation Shows Promise in Selected Patients With Hypertension
High blood pressure is a major risk factor for cardiovascular disease, including heart attack and stroke. Many patients receiving treatment for hypertension still remain above recommended blood pressure... Read more
EHR Model Flags High-Risk Periods in Patients with Metastatic Breast Cancer
Determining when patients with metastatic breast cancer are nearing the end of life remains difficult, often leading to intensive interventions with limited benefit. Prognostic uncertainty can delay goals-of-care... Read moreMedical Imaging
view channel
Public Chest CT Dataset Supports Explainable AI in Diagnostic Radiology
Chest computed tomography scans generate complex three-dimensional images that can be difficult for artificial intelligence systems to explain clearly. Clinicians need to verify AI findings before using... Read more
PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI
Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more
AI Software Detects Osteoporosis from Routine CT Scans
Osteoporosis can progress for years without pain, leaving bone loss undetected until a fracture or back pain prompts testing. By that point, bone loss may already be advanced. Bone density testing is not... Read more
AI Model Uses Pretreatment CT Scans to Predict Immunotherapy-Related Pneumonitis Risk
Pneumonitis is a potentially life-threatening form of lung inflammation that affects about 10% of patients with lung cancer receiving immunotherapy. Because it can be difficult to predict before symptoms... Read moreHealth IT
view channel
EHR Alerts Support Dosing, Sedation, and Shock Recognition in Cardiac Care
Electronic health record alerts can add to clinician workload when they are poorly targeted. In critical cardiac care, however, delayed decisions can affect treatment timing, sedation exposure, and escalation... Read more
Adaptive Radiation QA Software Gains Validation for NeoArc Treatments
Adaptive radiation therapy allows clinicians to adjust treatment plans to daily anatomical changes such as tumor shrinkage, weight loss, or organ movement, improving precision while limiting exposure to... Read morePoint of Care
view channel
Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes
Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more







